Israel Englander’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,773
| Closed | -$420K | – | 6432 |
|
|
2026
Q1 | $420K | Sell |
6,773
-9,575
| -59% | -$603K | ﹤0.01% | 4852 |
|
|
2025
Q4 | $915K | Sell |
16,348
-4,208
| -20% | -$244K | ﹤0.01% | 4546 |
|
|
2025
Q3 | $1.29M | Sell |
20,556
-9,424
| -31% | -$557K | ﹤0.01% | 4412 |
|
|
2025
Q2 | $1.71M | Sell |
29,980
-2,028
| -6% | -$110K | ﹤0.01% | 4016 |
|
|
2025
Q1 | $1.79M | Sell |
32,008
-79
| -0.2% | -$4.73K | ﹤0.01% | 3883 |
|
|
2024
Q4 | $1.97M | Buy |
32,087
+6,975
| +28% | +$451K | ﹤0.01% | 3658 |
|
|
2024
Q3 | $1.68M | Sell |
25,112
-13,852
| -36% | -$940K | ﹤0.01% | 3860 |
|
|
2024
Q2 | $2.6M | Sell |
38,964
-11,638
| -23% | -$792K | ﹤0.01% | 3300 |
|
|
2024
Q1 | $3.6M | Buy |
50,602
+30,694
| +154% | +$2.3M | ﹤0.01% | 3211 |
|
|
2023
Q4 | $1.68M | Sell |
19,908
-2,081
| -9% | -$173K | ﹤0.01% | 3751 |
|
|
2023
Q3 | $1.89M | Buy |
21,989
+5,633
| +34% | +$520K | ﹤0.01% | 3599 |
|
|
2023
Q2 | $1.52M | Buy |
16,356
+8,205
| +101% | +$773K | ﹤0.01% | 3703 |
|
|
2023
Q1 | $772K | Buy |
+8,151
| New | +$749K | ﹤0.01% | 4316 |
|
|
2022
Q2 | – | Sell |
-3,465
| Closed | -$311K | – | 7533 |
|
|
2022
Q1 | $311K | Buy |
+3,465
| New | +$319K | ﹤0.01% | 5506 |
|
|
2021
Q3 | – | Sell |
-2,960
| Closed | -$252K | – | 7275 |
|
|
2021
Q2 | $252K | Sell |
2,960
-8,493
| -74% | -$735K | ﹤0.01% | 5866 |
|
|
2021
Q1 | $992K | Sell |
11,453
-3,949
| -26% | -$347K | ﹤0.01% | 4224 |
|
|
2020
Q4 | $1.3M | Sell |
15,402
-10,642
| -41% | -$907K | ﹤0.01% | 3561 |
|
|
2020
Q3 | $2.08K | Buy |
26,044
+5,139
| +25% | +$426K | ﹤0.01% | 2571 |
|
|
2020
Q2 | $1.85M | Buy |
+20,905
| New | +$1.88M | ﹤0.01% | 2594 |
|
|
2019
Q2 | – | Sell |
-2,289
| Closed | -$202K | – | 4478 |
|
|
2019
Q1 | $202K | Buy |
+2,289
| New | +$201K | ﹤0.01% | 3732 |
|
|
2018
Q4 | – | Sell |
-4,207
| Closed | -$396K | – | 4197 |
|
|
2018
Q3 | $396K | Buy |
4,207
+2,379
| +130% | +$227K | ﹤0.01% | 3361 |
|
|
2018
Q2 | $201K | Buy |
+1,828
| New | +$191K | ﹤0.01% | 3559 |
|
|
2018
Q1 | – | Sell |
-6,392
| Closed | -$520K | – | 4094 |
|
|
2017
Q4 | $520K | Sell |
6,392
-4,125
| -39% | -$322K | ﹤0.01% | 3075 |
|
|
2017
Q3 | $774K | Sell |
10,517
-4,975
| -32% | -$358K | ﹤0.01% | 2646 |
|
|
2017
Q2 | $1.12M | Buy |
15,492
+10,664
| +221% | +$702K | ﹤0.01% | 2388 |
|
|
2017
Q1 | $301K | Sell |
4,828
-249
| -5% | -$15.7K | ﹤0.01% | 3042 |
|
|
2016
Q4 | $369K | Buy |
+5,077
| New | +$330K | ﹤0.01% | 2809 |
|
Other funds holding UTMD
BIP
MA
RHJA
Israel Englander's UTMD Position: Q2 2026 in Review
Israel Englander sold out of Utah Medical Products (UTMD) in Q2 2026, closing a stake of 6,773 shares — an estimated $420K sold.
Israel Englander first reported a position in UTMD in Q4 2016 and held it in 27 quarters. The position peaked at $3.6M in Q1 2024. 113 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.
- Israel Englander reported no remaining Utah Medical Products position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 6,773 Utah Medical Products shares in Q2 2026, an estimated $420K.
- Israel Englander first reported a position in Utah Medical Products in Q4 2016 and held it in 27 quarters.
- Israel Englander's Utah Medical Products position peaked at $3.6M in Q1 2024.
- 113 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.